Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Receptors, Dopamine D2 (physiology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Receptors, Dopamine D2 (metabolism) < Receptors, Dopamine D2 (physiology) < Receptors, Dopamine D3  Facettes :

List of bibliographic references indexed by Receptors, Dopamine D2 (physiology)

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]
Ident.Authors (with country if any)Title
002763 (2008) Paolo Calabresi [Italie] ; Massimiliano Di Filippo [Italie] ; Veronica Ghiglieri [Italie] ; Barbara Picconi [Italie]Molecular mechanisms underlying levodopa‐induced dyskinesia
003030 (2007) Kjell Fuxe [Suède] ; Daniel Marcellino [Suède] ; Susanna Genedani [Italie] ; Luigi Agnati [Italie]Adenosine A2A receptors, dopamine D2 receptors and their interactions in Parkinson's disease
003185 (2006) Matthias Reimold [Allemagne] ; Christoph Globas [Allemagne] ; Marc Gleichmann [Allemagne] ; Michael Schulze [Allemagne] ; Christian Gerloff [Allemagne] ; Roland Bares [Allemagne] ; H. Machulla [Allemagne] ; Katrin Bürk [Allemagne]Spinocerebellar ataxia type 1, 2, and 3 and restless legs syndrome: Striatal dopamine D2 receptor status investigated by [11C]raclopride positron emission tomography
003477 (2006) Stefanie Klaffke [Allemagne] ; Andrea A. Kuhn [Allemagne] ; Michail Plotkin [Allemagne] ; Holger Amthauer [Allemagne] ; Daniel Harnack [Allemagne] ; Roland Felix [Allemagne] ; Andreas Kupsch [Allemagne]Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration
003589 (2006) Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France]Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors
003C79 (2004) Valtteri Kaasinen [Finlande] ; Sargo Aalto [Finlande] ; Kjell N Gren [Finlande] ; Juha O. Rinne [Finlande]Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease
003E30 (2004) Sylvia M. Boesch [Autriche] ; Eveline Donnemiller [Autriche] ; Jörg Müller [Autriche] ; Klaus Seppi [Autriche] ; Helga Weirich-Schwaiger [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Abnormalities of dopaminergic neurotransmission in SCA2: A combined 123I‐βCIT and 123I‐IBZM SPECT study
004381 (2002) Mehran Ghaemi [Allemagne] ; Jan Raethjen [Allemagne] ; Rüdiger Hilker [Allemagne] ; Jobst Rudolf [Allemagne] ; Jan Sobesky [Allemagne] ; Günther Deuschl [Allemagne] ; Wolf-Dieter Heiss [Allemagne]Monosymptomatic resting tremor and Parkinson's disease: A multitracer positron emission tomographic study
004532 (2002) Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada]Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP
004A04 (2000) Paul R. Jarman [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Charles Davie [Royaume-Uni] ; Simon J. R. Heales [Royaume-Uni] ; Nora Turjanski [Royaume-Uni] ; Simon D. Taylor-Robinson [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni]Paroxysmal dystonic choreoathetosis: Clinical features and investigation of pathophysiology in a large family
004C34 (1999) Christine Dentresangle [France] ; Laurent Veyre [France] ; Didier Le Bars [France] ; Christian Pierre [France] ; Frank Lavenne [France] ; Pierre Pollak [France] ; Jeanine Guerin [France] ; Jean-Claude Froment [France] ; Emmanuel Brousolle [France]Striatal D2 dopamine receptor status in Parkinson's disease: An [18F]dopa and [11C]Raclopride PET study
005034 (1998) Ronald K. B. Pearce [Royaume-Uni] ; Tara Banerji [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni]De novo administration of ropinirole and bromocriptine induces less dyskinesia than L‐dopa in the MPTP‐treated marmoset
005098 (1998) Wenning [Autriche] ; Eveline Donnemiller [Autriche] ; Roberta Granata [Autriche] ; Georg Riccabona [Autriche] ; Werner Poewe [Autriche]123I‐β‐CIT and 123I‐IBZM‐SPECT scanning in levodopa‐naive Parkinson's disease
005308 (1997) G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. T. Savino [Argentine] ; M. Mora [Argentine] ; F. J. E. Stefano [Argentine] ; Gershanik [Argentine]Mechanism of action of clozapine‐induced modification of motor behavior in an animal model of the “super‐off” phenomenon
005319 (1997) Angelo Antonini [Suisse] ; Johannes Schwarz [Suisse] ; Wolfgang H. Oertel [Suisse] ; Oliver Pogarell [Suisse] ; Leenders [Suisse, Allemagne]Long‐term changes of striatal dopamine D2 Receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]Raclopride
005633 (1996) Jauss [Allemagne] ; P. Krack [Allemagne] ; M. Franz [Allemagne] ; R. Klett [Allemagne] ; R. Bauer [Allemagne] ; B. Gallhofer [Allemagne] ; W. Dorndorf [Allemagne]Imaging of dopamine receptors with [123I]iodobenzamide single‐photon emission–computed tomography in neuroleptic malignant syndrome
005660 (1996) L. Verhagen Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; D. De Jong [États-Unis] ; M. M. Mouradian [États-Unis] ; Chase [États-Unis]Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease
005A77 (1994) Trugman [États-Unis] ; Robert Leadbetter [États-Unis] ; Michael E. Zalis [États-Unis] ; Rose O. Burgdorf [États-Unis] ; G. Frederick Wooten [États-Unis]Treatment of severe axial tardive dystonia with clozapine: Case report and hypothesis
005A84 (1994) R. J. Vermeulen [Pays-Bas] ; Drukarch [Pays-Bas] ; M. C. R. Sahadat [Pays-Bas] ; C. Goosen [Pays-Bas] ; E. C. Wolters [Pays-Bas] ; J. C. Stoof [Pays-Bas]The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐lesioned parkinsonian rhesus monkeys
005B26 (1994) Belluzzi [États-Unis] ; E. F. Domino [États-Unis] ; J. M. May [États-Unis] ; K. S. Bankiewicz [États-Unis] ; D. A. Mcafee [États-Unis]N‐0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease
005B87 (1994) M. Koepp [Allemagne] ; L. Schelosky [Allemagne] ; I. Cordes [Allemagne] ; M. Cordes [Allemagne] ; Poewe [Allemagne]Dystonis in ataxia telangiectasia: Report of a case with putaminal lesions and decreased striatal [123I]Iodobenzamide Binding

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Receptors, Dopamine D2 (physiology)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Receptors, Dopamine D2 (physiology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Receptors, Dopamine D2 (physiology)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024